Bass James Edward

CIK 00016623211 companyIRVING, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001662321

Recent Transactions

35 trades

Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2020-06-10$82.15/sh+821→ 821 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2020-06-10+6,300→ 6,300 total
Gift
REATA PHARMACEUTICALS INC
Class A common stock
2019-11-20−6,000→ 45,479 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2019-06-12$57.59/sh+1,065→ 1,065 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2019-06-12+9,000→ 9,000 total
Gift
REATA PHARMACEUTICALS INC
Class A common stock
2019-03-05−2,631→ 51,479 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-03-05$100.29/sh−5,852→ 11,703 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2018-12-20$52.12/sh+888→ 54,110 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2018-11-16$59.33/sh+1,679→ 53,222 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2018-07-25$78.34/sh+888→ 51,543 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2018-06-13+8,000→ 8,000 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2018-06-13$26.49/sh+693→ 693 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-11-15$24.02/sh+3,888→ 50,655 total
Gift
REATA PHARMACEUTICALS INC
Class A common stock
2017-09-20−5,322→ 46,767 total
Gift
REATA PHARMACEUTICALS INC
Class A common stock
2017-09-19−15,322→ 52,089 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2017-08-01$31.00/sh+8,064→ 67,411 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2017-06-14$17.46/sh+1,052→ 1,052 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2017-06-14+6,000→ 6,000 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2017-01-05−38,447→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2017-01-05+38,447→ 41,902 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2017-01-05−28,762→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2017-01-05−16,107→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2017-01-05+28,762→ 59,347 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2017-01-05+16,107→ 17,555 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-12-14$21.76/sh+5,000→ 30,585 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2016-12-07$14.54/sh+632→ 632 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2016-12-07+6,000→ 6,000 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−2,585→ 28,762 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01+3,455→ 3,455 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01+1,448→ 1,448 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−3,455→ 38,447 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01$13.28/sh+5,000→ 5,000 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01+2,585→ 7,585 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2016-06-01−1,448→ 16,107 total
Purchase
REATA PHARMACEUTICALS INC
Class A common stock
2016-06-01$11.00/sh+18,000→ 25,585 total

Companies

REATA PHARMACEUTICALS INC
Director

Recent Filings

Address

2801 GATEWAY DRIVE SUITE 150

IRVING, TX, 75063

View on SEC.gov